Indication

Mucocutaneous herpes simplex

Mucocutaneous herpes simplex refers to a localized viral infection of the skin and mucous membranes caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2). Read more about Mucocutaneous herpes simplex

69 drugs 64 manufacturers

Advertisement

Drugs that treat it

Common Mucocutaneous herpes simplex therapies.

Showing 37–45 of 69 drugs

ACYCLOVIR

ANTIVIRAL - HERPES VIRUSES·CHICKENPOX·+9
Mylan Pharmaceuticals

ACYCLOVIR

TOPICAL ANTIVIRALS·GENITAL HERPES SIMPLEX·+1
TORRENT PHARMAC

ACYCLOVIR

TOPICAL ANTIVIRALS·GENITAL HERPES SIMPLEX·+1
ALEMBIC PHARMAC

ACYCLOVIR

ANTIVIRAL - HERPES VIRUSES·GENITAL HERPES SIMPLEX·+1
ZYDUS PHARMACEU

ACYCLOVIR

TOPICAL ANTIVIRALS·GENITAL HERPES SIMPLEX·+1
BUREL PHARMACEU

ACYCLOVIR

GENITAL HERPES SIMPLEX·+1
Cosette Pharmaceuticals

ACYCLOVIR

ANTIVIRAL - HERPES VIRUSES·CHICKENPOX·+9
BLENHEIM PHARMA

ACYCLOVIR

ANTIVIRAL - HERPES VIRUSES·CHICKENPOX·+9
ATLANTIC BIOLOG

ACYCLOVIR

TOPICAL ANTIVIRALS·GENITAL HERPES SIMPLEX·+1
MACLEODS PHARMA
Filter & compare in the drug finder →Opens the drug finder with Mucocutaneous herpes simplex preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mucocutaneous herpes simplex.

Mucocutaneous herpes simplex refers to a localized viral infection of the skin and mucous membranes caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2).

It primarily affects the integumentary and mucosal epithelial surfaces—most frequently involving the oral, perioral, or anogenital regions—in both immunocompetent and immunocompromised hosts.

Pathophysiologically, the virus replicates within epithelial cells following primary exposure or reactivation from latent sensory nerve ganglia, clinically producing clusters of painful, fluid-filled vesicles on an erythematous base that subsequently rupture, ulcerate, and crust.

While typically episodic and self-limited in healthy individuals, the condition can present with prolonged, extensive, or necrotic ulcerations in patients with impaired cell-mediated immunity.

Personalize your experience

Follow Mucocutaneous herpes simplex and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it